CNS Drugs (journal)
Academic journal
| Discipline | Drug therapy, pharmacology |
|---|---|
| Language | English |
| Edited by | Kate Palmer and Sue Pochon |
| Publication details | |
| History | 1994-present |
| Publisher | Adis International (Springer Nature) (New Zealand) |
| Frequency | Monthly |
Open access | Hybrid |
Impact factor | 5.749 (2020) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | CNS Drugs |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 1172-7047 (print) 1179-1934 (web) |
| OCLC no. | 477236411 |
| Links | |
| |
CNS Drugs is a monthly peer-reviewed medical journal published by Adis International (Springer Nature) that covers drug treatment of psychiatric and neurological disorders.
Abstracting and indexing
The journal is abstracted and indexed in:
- MEDLINE
- EMBASE
- International Pharmaceutical Abstracts
- BIOSIS Previews
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Science Citation Index
- Neuroscience Citation Index
- PASCAL
- Chemical Abstracts Service
- PsycINFO
According to the Journal Citation Reports, the journal has a 2022 impact factor of 6.0.[1]
References
- ^ "InCites Journal Citation Reports". apps.clarivate.com. Retrieved 2018-09-10.
External links
- Official website
- v
- t
- e
